Eli Lilly (LLY) Other Non Operating Income (2009 - 2012)

Eli Lilly has reported Other Non Operating Income for 4 years, with the latest figure at -$26.8 million in Q1 2012.

• For the quarter ending Q1 2012, Other Non Operating Income fell 240.31% year-over-year to -$26.8 million; the trailing twelve-month figure through Mar 2012 stood at -$118.8 million (down 428.18% YoY), and the FY2011 full-year result was -$72.9 million, down 156.69% from the prior year.
• Other Non Operating Income for Q1 2012 stood at -$26.8 million, down from -$1.1 million in the prior quarter.
• The five-year high for Other Non Operating Income was $111.5 million in Q1 2010, with the low at -$205.1 million in Q4 2009.
• Historically, Other Non Operating Income has averaged -$12.2 million across 4 years, with a median of -$1.1 million in 2011.
• Annual changes were most pronounced in 2010 — Other Non Operating Income soared 257.71% — and 2011, when it tumbled 758.7%.
• Eli Lilly's Other Non Operating Income stood at -$205.1 million in 2009, then jumped by 95.03% to -$10.2 million in 2010, then surged by 89.22% to -$1.1 million in 2011, then plunged by 2336.36% to -$26.8 million in 2012.
• The last three Other Non Operating Income figures came in at -$26.8 million (Q1 2012), -$1.1 million (Q4 2011), and -$60.6 million (Q3 2011), per Business Quant data.